MEDiSTRAVA
The Business Development Director for Real-World Insights at Inizio Medical (MEDiSTRAVA Specialised Services) will lead new business growth and help position the agency as a strategic partner for pharmaceutical and biotech clients. This US-remote role focuses on winning opportunities in real-world evidence, medical affairs support, and publications while representing the agency to senior client stakeholders. The role sits within the agency’s commercial function and supports strategic growth across biopharma and life sciences.
Headquarters
London, England, United Kingdom
Company Size
201-500 employees
Founded
2019
MEDiSTRAVA is an integrated medical solutions partner, part of Inizio Medical, that supports biotech and biopharma teams from start-up through commercialization and beyond. They provide specialized services across medical strategy and excellence, patient engagement, clinical trials optimization, medical analytics and innovation, value and evidence, and corporate and investor communications. MEDiSTRAVA combines deep expert knowledge with a fully integrated approach to help life sciences companies achieve product approval, market access, and long-term corporate success.
AdvanCell Appoints Philina Lee, PhD as Chief Executive Officer to Lead US Expansion and Drive Global Growth
Nov 17, 2025
Huntsworth’s MediStrava acquires MedEvoke
Jul 8, 2021
‘Probably the largest drug launch company on the planet’: Huntsworth/Ashfield union spawns Inizio
Jun 30, 2022
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MEDiSTRAVA.
Huntsworth acquires medical analytics firm MedEvoke
Aug 14, 2021